JANX logo

Janux Therapeutics (JANX) Accounts payable

annual accounts payable:

$4.03M+$1.60M(+66.09%)
December 31, 2024

Summary

  • As of today (July 1, 2025), JANX annual accounts payable is $4.03 million, with the most recent change of +$1.60 million (+66.09%) on December 31, 2024.
  • During the last 3 years, JANX annual accounts payable has risen by +$1.57 million (+63.79%).
  • JANX annual accounts payable is now at all-time high.

Performance

JANX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

quarterly accounts payable:

$2.35M-$1.68M(-41.60%)
March 31, 2025

Summary

  • As of today (July 1, 2025), JANX quarterly accounts payable is $2.35 million, with the most recent change of -$1.68 million (-41.60%) on March 31, 2025.
  • Over the past year, JANX quarterly accounts payable has increased by +$97.00 thousand (+4.30%).
  • JANX quarterly accounts payable is now -41.60% below its all-time high of $4.03 million, reached on December 31, 2024.

Performance

JANX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

JANX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+66.1%+4.3%
3 y3 years+63.8%+21.3%
5 y5 years+1407.9%-

JANX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+86.5%-41.6%+87.6%
5 y5-yearat high+1407.9%-41.6%+564.1%
alltimeall timeat high+1407.9%-41.6%+564.1%

JANX Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$2.35M(-41.6%)
Dec 2024
$4.03M(+66.1%)
$4.03M(+63.5%)
Sep 2024
-
$2.46M(+96.5%)
Jun 2024
-
$1.25M(-44.4%)
Mar 2024
-
$2.25M(-7.0%)
Dec 2023
$2.42M(+12.3%)
$2.42M(-3.2%)
Sep 2023
-
$2.50M(+31.2%)
Jun 2023
-
$1.91M(-6.9%)
Mar 2023
-
$2.05M(-5.0%)
DateAnnualQuarterly
Dec 2022
$2.16M(-12.2%)
$2.16M(-24.7%)
Sep 2022
-
$2.87M(-4.5%)
Jun 2022
-
$3.00M(+54.7%)
Mar 2022
-
$1.94M(-21.1%)
Dec 2021
$2.46M(+474.3%)
$2.46M(-32.0%)
Sep 2021
-
$3.61M(+920.6%)
Jun 2021
-
$354.00K(-58.7%)
Mar 2021
-
$857.00K(+100.2%)
Dec 2020
$428.00K(+60.3%)
$428.00K
Dec 2019
$267.00K
-

FAQ

  • What is Janux Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Janux Therapeutics?
  • What is Janux Therapeutics annual accounts payable year-on-year change?
  • What is Janux Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Janux Therapeutics?
  • What is Janux Therapeutics quarterly accounts payable year-on-year change?

What is Janux Therapeutics annual accounts payable?

The current annual accounts payable of JANX is $4.03M

What is the all time high annual accounts payable for Janux Therapeutics?

Janux Therapeutics all-time high annual accounts payable is $4.03M

What is Janux Therapeutics annual accounts payable year-on-year change?

Over the past year, JANX annual accounts payable has changed by +$1.60M (+66.09%)

What is Janux Therapeutics quarterly accounts payable?

The current quarterly accounts payable of JANX is $2.35M

What is the all time high quarterly accounts payable for Janux Therapeutics?

Janux Therapeutics all-time high quarterly accounts payable is $4.03M

What is Janux Therapeutics quarterly accounts payable year-on-year change?

Over the past year, JANX quarterly accounts payable has changed by +$97.00K (+4.30%)
On this page